Financials • Money Center Banking, Investment Banking & Asset Management • SIC 6021
$337.04 ▼ -6.54
(-1.90%)
MKT CAP: $900.38B • VOL: 7.83M
52W L $279 52W H $367
JPM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-13 | FY 2024
FILED 2026-02-13 | FY 2023
FILED 2026-02-13 | FY 2022
FILED 2025-02-14 | FY 2021
FILED 2024-02-16 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $182.45B | $177.56B | $158.10B | $128.69B | $121.65B |
| YoY Revenue Growth % | +2.8% | +12.3% | +22.9% | +5.8% | +1.4% |
| Gross Profit | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — |
| Operating Income (EBIT) | $72.59B | $75.08B | $61.61B | $46.17B | $59.56B |
| Operating Margin % | 39.8% | 42.3% | 39.0% | 35.9% | 49.0% |
| Net Income (GAAP) | $57.05B | $58.47B | $49.55B | $37.68B | $48.33B |
| EBITDA (Normalized) | $81.42B | $83.02B | $69.12B | $53.22B | $67.49B |
| Diluted EPS ($/sh) | $20.02 | $19.75 | $16.23 | $12.09 | $15.36 |
| Operating Cash Flow (OCF) | -$147.78B | -$42.01B | $12.97B | $107.12B | $78.08B |
| Capital Expenditures (CapEx) | — | — | — | — | — |
| Free Cash Flow (FCF) | -$147.78B | -$42.01B | $12.97B | $107.12B | $78.08B |
| FCF Margin % | -81.0% | -23.7% | 8.2% | 83.2% | 64.2% |
| Return on Invested Capital (ROIC %) | 15.7% | 17.0% | 15.1% | 12.9% | 16.4% |
| Cash & Short-Term Equivalents | $343.34B | $469.32B | $624.15B | $567.23B | $740.83B |
| Total Debt (Short + Long Term) | $64.78B | $52.89B | $44.71B | $44.03B | $53.59B |
| Total Stockholders' Equity | $362.44B | $344.76B | $327.88B | $292.33B | $294.13B |
| LINE ITEM (USD / %) | Q2 2026
FILED 2026-08-06 | Q1 2026
FILED 2026-05-01 | Q4 2025
FILED 2026-02-13 | Q3 2025
FILED 2025-11-04 | Q2 2025
FILED 2026-08-06 | Q1 2025
FILED 2026-05-01 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $57.35B | $49.84B | $45.80B | $46.43B | $44.91B | $45.31B |
| YoY Revenue Growth % | +27.7% | +10.0% | +7.1% | +8.8% | -10.5% | +8.1% |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — | — |
| Operating Income (EBIT) | $27.52B | $20.48B | $17.16B | $18.74B | $18.28B | $18.41B |
| Operating Margin % | 48.0% | 41.1% | 37.5% | 40.4% | 40.7% | 40.6% |
| Net Income (GAAP) | $21.16B | $16.49B | $13.03B | $14.39B | $14.99B | $14.64B |
| EBITDA (Normalized) | $30.27B | $22.84B | $18.88B | $20.62B | $20.11B | $20.44B |
| Diluted EPS ($/sh) | $7.70 | $5.94 | $4.64 | $5.07 | $5.24 | $5.07 |
| Operating Cash Flow (OCF) | -$25.28B | -$211.76B | $119.72B | -$45.21B | $29.55B | -$251.84B |
| Capital Expenditures (CapEx) | — | — | — | — | — | — |
| Free Cash Flow (FCF) | -$25.28B | -$211.76B | $119.72B | -$45.21B | $29.55B | -$251.84B |
| FCF Margin % | -44.1% | -424.9% | 261.4% | -97.4% | 65.8% | -555.8% |
| Return on Invested Capital (ROIC %) | 22.6% | 18.1% | 14.4% | 16.0% | 16.8% | 16.7% |
| Cash & Short-Term Equivalents | $309.81B | $312.14B | $343.34B | $303.44B | $420.33B | $425.90B |
| Total Debt (Short + Long Term) | $72.43B | $68.05B | $64.78B | $69.36B | $65.29B | $64.98B |
| Total Stockholders' Equity | $374.60B | $364.04B | $362.44B | $360.21B | $356.92B | $351.42B |